Envista (NYSE:NVST) Stock Rating Upgraded by Citigroup

Envista (NYSE:NVST) was upgraded by investment analysts at Citigroup to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Several other research firms also recently commented on NVST. Robert W. Baird set a $30.00 price objective on Envista in a research note on Friday, February 6th. Wells Fargo & Company lifted their target price on shares of Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Leerink Partners set a $35.00 target price on shares of Envista and gave the company an “outperform” rating in a report on Friday, February 6th. Piper Sandler reaffirmed a “neutral” rating and issued a $25.00 target price (up from $21.00) on shares of Envista in a report on Friday, February 6th. Finally, Weiss Ratings raised shares of Envista from a “sell (d)” rating to a “hold (c-)” rating in a report on Tuesday, February 17th. Seven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Envista presently has a consensus rating of “Hold” and a consensus price target of $27.69.

Envista Trading Down 0.4%

Shares of Envista stock opened at $26.91 on Wednesday. Envista has a 1 year low of $14.72 and a 1 year high of $30.42. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38. The company has a market capitalization of $4.39 billion, a P/E ratio of 96.11, a PEG ratio of 1.85 and a beta of 0.98. The company’s fifty day moving average is $27.16 and its two-hundred day moving average is $23.41.

Envista (NYSE:NVST) last posted its quarterly earnings data on Thursday, February 5th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.The company’s revenue for the quarter was up 15.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts forecast that Envista will post 1 earnings per share for the current year.

Insider Buying and Selling

In related news, SVP Mischa Reis sold 9,675 shares of the business’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the sale, the senior vice president owned 32,382 shares of the company’s stock, valued at approximately $971,460. The trade was a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.66% of the company’s stock.

Institutional Trading of Envista

A number of institutional investors have recently added to or reduced their stakes in the stock. Parallel Advisors LLC boosted its holdings in Envista by 13.1% during the fourth quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock worth $69,000 after buying an additional 367 shares in the last quarter. Bank of Montreal Can boosted its holdings in Envista by 1.4% during the fourth quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock worth $568,000 after buying an additional 372 shares in the last quarter. Sepio Capital LP lifted its holdings in shares of Envista by 1.2% in the fourth quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock valued at $687,000 after purchasing an additional 374 shares in the last quarter. Deutsche Bank AG lifted its holdings in shares of Envista by 2.9% in the fourth quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock valued at $378,000 after purchasing an additional 484 shares in the last quarter. Finally, UMB Bank n.a. lifted its holdings in shares of Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after purchasing an additional 636 shares in the last quarter.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.